JAZZ Related Downgrades
-
Barclays Initiating Coverage: A Seamless Approach to Biopharmaceuticals
-
WBB Securities Downgrades Jazz Pharmaceuticals (JAZZ) to Hold
-
WBB Securities Downgrades Jazz Pharmaceuticals (JAZZ) to Buy
-
Jefferies Downgrades Jazz Pharma (JAZZ) to Hold
-
CapStone Cuts Jazz Pharma (JAZZ) to Hold; Concerned with Likelihood That FDA Will Approve for JZP-6
-
Barclays Downgrades Jazz Pharma (JAZZ) Two-Notches To Underweight
Back to JAZZ Stock Lookup
